These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21167226)

  • 1. Hansenula polymorpha expressed heat shock protein gp96 exerts potent T cell activation activity as an adjuvant.
    Li Y; Song H; Li J; Wang Y; Yan X; Zhao B; Zhang X; Wang S; Chen L; Qiu B; Meng S
    J Biotechnol; 2011 Feb; 151(4):343-9. PubMed ID: 21167226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-step single-chain Fv recombinant antibody-based purification of gp96 for vaccine development.
    Arnold-Schild D; Kleist C; Welschof M; Opelz G; Rammensee HG; Schild H; Terness P
    Cancer Res; 2000 Aug; 60(15):4175-8. PubMed ID: 10945626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell surface expression of the endoplasmic reticular heat shock protein gp96 is phylogenetically conserved.
    Robert J; Ménoret A; Cohen N
    J Immunol; 1999 Oct; 163(8):4133-9. PubMed ID: 10510348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TAT-mediated gp96 transduction to APCs enhances gp96-induced antiviral and antitumor T cell responses.
    Zhao B; Wang Y; Zhang Y; Li Y; Zhang X; Xu Y; Chen L; Li C; Ju Y; Meng S
    Vaccine; 2013 Jan; 31(3):545-52. PubMed ID: 23149267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficient expression of exogenous human gp96 gene in tumor cells].
    Yue PB; Yang SD; Huang CZ; Zhao M; Du F; Lin L; Yu Q; Zhou QB
    Ai Zheng; 2002 Feb; 21(2):142-5. PubMed ID: 12479062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treg suppress CTL responses upon immunization with HSP gp96.
    Liu Z; Li X; Qiu L; Zhang X; Chen L; Cao S; Wang F; Meng S
    Eur J Immunol; 2009 Nov; 39(11):3110-20. PubMed ID: 19839010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secreted heat shock protein gp96-Ig: an innovative vaccine approach.
    Strbo N; Podack ER
    Am J Reprod Immunol; 2008 May; 59(5):407-16. PubMed ID: 18405311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
    Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z
    Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cloning, expression and purification of the C-terminal section of murine heat shock protein gp96].
    Han JL; Li HT; Li JL; Tien P
    Sheng Wu Gong Cheng Xue Bao; 2004 Jul; 20(4):619-22. PubMed ID: 15969000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Large-scale in vitro preparation of new gp96 tumor vaccine and analysis of its induction of specific anti-tumor immunoresponses].
    Yan X; Li C; Zhang X; Ju Y; Zhao B; Meng S
    Sheng Wu Gong Cheng Xue Bao; 2011 Nov; 27(11):1598-605. PubMed ID: 22393714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression levels of stress protein gp96 are not limiting for major histocompatibility complex class I-restricted antigen presentation.
    Lammert E; Arnold D; Rammensee HG; Schild H
    Eur J Immunol; 1996 Apr; 26(4):875-9. PubMed ID: 8625982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies.
    Bolhassani A; Zahedifard F; Taghikhani M; Rafati S
    Vaccine; 2008 Jun; 26(26):3362-70. PubMed ID: 18471945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immune activity of heat shock protein gp96 and its application in active immunotherapy for tumor and infectious diseases].
    Xu Y; Wang S; Zhang X; Meng S
    Sheng Wu Gong Cheng Xue Bao; 2012 Mar; 28(3):261-6. PubMed ID: 22712385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing the potency of HBV DNA vaccines using fusion genes of HBV-specific antigens and the N-terminal fragment of gp96.
    Yan J; Liu X; Wang Y; Jiang X; Liu H; Wang M; Zhu X; Wu M; Tien P
    J Gene Med; 2007 Feb; 9(2):107-21. PubMed ID: 17256801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96.
    Qian J; Wang S; Yang J; Xie J; Lin P; Freeman ME; Yi Q
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8808-15. PubMed ID: 16361569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the negative co-stimulatory ligand sCD152 in the yeast, Pichia pastoris, and its regulation of antigen specific immune responses.
    Zhu N; Gao N; Wang Y; Wang X; Yang Y
    Int Immunopharmacol; 2004 Jan; 4(1):139-48. PubMed ID: 14975368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suspension culture process of MethA tumor cell for the production of heat-shock protein glycoprotein 96: process optimization in spinner flasks.
    Tang YJ; Li HM; Hamel JF
    Biotechnol Prog; 2007; 23(6):1363-77. PubMed ID: 17944484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of heat shock protein gp96 on human dendritic cell maturation and CTL expansion.
    Zhang Y; Zan Y; Shan M; Liu C; Shi M; Li W; Zhang Z; Liu N; Wang F; Zhong W; Liao F; Gao GF; Tien P
    Biochem Biophys Res Commun; 2006 Jun; 344(2):581-7. PubMed ID: 16630554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of murine CTL by a hepatitis B virus-specific peptide and evaluation of the adjuvant effect of heat shock protein glycoprotein 96 and its terminal fragments.
    Li H; Zhou M; Han J; Zhu X; Dong T; Gao GF; Tien P
    J Immunol; 2005 Jan; 174(1):195-204. PubMed ID: 15611241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96.
    Ishii T; Udono H; Yamano T; Ohta H; Uenaka A; Ono T; Hizuta A; Tanaka N; Srivastava PK; Nakayama E
    J Immunol; 1999 Feb; 162(3):1303-9. PubMed ID: 9973383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.